These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 3513670
1. Oxitropium bromide, a new anticholinergic bronchodilator. Skorodin MS, Gross NJ, Moritz T, King FW, Armstrong W, Wells D, Galavan E, Slutsky L. Ann Allergy; 1986 Mar; 56(3):229-32. PubMed ID: 3513670 [Abstract] [Full Text] [Related]
2. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug. Frith PA, Jenner B, Dangerfield R, Atkinson J, Drennan C. Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822 [Abstract] [Full Text] [Related]
3. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS. Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [Abstract] [Full Text] [Related]
4. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Ikeda A, Nishimura K, Koyama H, Izumi T. Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652 [Abstract] [Full Text] [Related]
5. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538 [Abstract] [Full Text] [Related]
6. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night]. Kneubühler HR, Kyd K, Benoit RC, Scherrer M. Schweiz Med Wochenschr; 1980 May 24; 110(21):812-6. PubMed ID: 7394499 [Abstract] [Full Text] [Related]
7. A comparison of oxitropium bromide and ipratropium bromide in asthma. Peel ET, Anderson G, Cheong B, Broderick N. Eur J Respir Dis; 1984 Feb 24; 65(2):106-8. PubMed ID: 6230249 [Abstract] [Full Text] [Related]
8. Duration of protection by oxitropium bromide against cholinergic challenge. Wilson NM, Green S, Coe C, Barnes PJ. Eur J Respir Dis; 1987 Nov 24; 71(5):455-8. PubMed ID: 3327703 [Abstract] [Full Text] [Related]
9. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise]. Suruda T, Nakamura H, Kobayashi H, Uetani K, Nishio M, Higashimoto Y, Funasako M, Ohata M. Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep 24; 31(9):1089-95. PubMed ID: 8255017 [Abstract] [Full Text] [Related]
10. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, Woodcock AA, Calverley PM. Eur Respir J; 1992 Jun 24; 5(6):659-64. PubMed ID: 1628722 [Abstract] [Full Text] [Related]
11. Anticholinergic drugs in airways obstruction. Anderson G. Postgrad Med J; 1983 Jun 24; 59 Suppl 3():64-5. PubMed ID: 6227880 [Abstract] [Full Text] [Related]
12. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease. Joos GF, Brusselle G, Derom E, Pauwels R. Int J Clin Pract; 2003 Dec 24; 57(10):906-9. PubMed ID: 14712894 [Abstract] [Full Text] [Related]
13. [Bronchodilator effects of an atropinic compound: oxitropium pressurized aerosol. Comparison with theophylline in asthma]. Gayrard P, Orehek J. Rev Pneumol Clin; 1984 Dec 24; 40(4):273-4. PubMed ID: 6545469 [Abstract] [Full Text] [Related]
14. Effect of theophylline in chronic obstructive lung disease. Umut S, Gemicioğlu B, Yildirim N, Barlas A, Ozüner Z. Int J Clin Pharmacol Ther Toxicol; 1992 May 24; 30(5):149-52. PubMed ID: 1592541 [Abstract] [Full Text] [Related]
15. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results. Minette A, Marcq M. Rev Inst Hyg Mines (Hasselt); 1979 May 24; 34(3):115-23. PubMed ID: 45210 [Abstract] [Full Text] [Related]
16. [The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis]. Vestri R, Philip-Joet F, Reynaud-Gaubert M, Arnaud A. Rev Mal Respir; 1990 May 24; 7(1):59-63. PubMed ID: 2251437 [Abstract] [Full Text] [Related]
17. Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD. Maesen FP, Smeets JJ, Costongs MA, Wald FD, Cornelissen PJ. Eur Respir J; 1993 Jul 24; 6(7):1031-6. PubMed ID: 8370429 [Abstract] [Full Text] [Related]
18. Oxitropium, salbutamol and their combination in asthma. Tukiainen P, Salorinne Y. Eur J Respir Dis; 1985 Jul 24; 67(1):31-6. PubMed ID: 3902498 [Abstract] [Full Text] [Related]
19. Oxitropium bromide improves exercise performance in patients with COPD. Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T. Chest; 1994 Dec 24; 106(6):1740-5. PubMed ID: 7988193 [Abstract] [Full Text] [Related]
20. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T. Am J Respir Crit Care Med; 2000 Jun 24; 161(6):1897-901. PubMed ID: 10852763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]